Sponsorship Opportunities at the Global Down Syndrome Foundation
Sheryl Crow and self-advocate perform at the DC Gala
The Global Down Syndrome Foundation is dedicated to significantly improving the lives of people with Down syndrome through RESEARCH, MEDICAL CARE, EDUCATION AND ADVOCACY.
Thank you for considering a sponsorship to the Global Down Syndrome Foundation. With your kind support, Global can continue to invest in the best medical professionals and scientists with truly life-changing results.
Be Beautiful Be Yourself Fashion Show
Witness a night of inspiration, advocacy, music and fun at the 2014 Global Down Syndrome Foundation’s Be Beautiful Be Yourself Fashion Show to be held Saturday, October 25, 2014 at the Sheraton Downtown Denver. Join over 1,200 guests, as they cheer on our beautiful models with Down syndrome who will walk the runway with sports personalities and other celebrities. This event provides critical funds for the Linda Crnic Institute for Down Syndrome on the Anschutz Medical Campus and the Sie Center for Down syndrome at Children’s Hospital Colorado.
Be Beautiful Be Yourself DC Gala
Each spring, the Global Down Syndrome Foundation hosts the Be Beautiful Be Yourself DC Gala. Washington’s most powerful and influential leaders and professional athletes gather to support Down syndrome research and advocacy at the Linda Crnic Institute for Down Syndrome. In 2014, Global held the Be Beautiful Be Yourself Gala at the Mayflower Renaissance Hotel, where the Multi-Platinum Singer-Songwriter Leona Lewis performed.
Alzheimer’s Disease & Down Syndrome Research Initiative
There are 27 National Institute on Aging (NIA) designated Alzheimer’s Disease Centers in the United States, but not one within a 600 mile radius of Denver or with a sub-specialty in Down syndrome. The Global Down Syndrome Foundation has partnered with the University of Colorado’s Department of Neurology at the Anschutz Medical Campus on this important initiative. Since Alzheimer’s disease and Down syndrome are mechanistically linked, funding for this initiative will accelerate the development of new treatments for both patients. For more information contact firstname.lastname@example.org or call 303-468-6669.